文献速递细胞病理与分子病理泌尿与男性生殖病理

肾上腺细胞学报告:多机构标准化报告系统提案

Adrenal gland cytology reporting: a multi-institutional proposal for a standardized reporting system.
PubMed 文献 · Cancer Cytopathol · 2022-03-04

本研究回顾性分析7家三级中心473例肾上腺细胞学标本,提出7级诊断分类系统。BACE与MAL分类与组织学随访符合率分别为100%和98.9%,MAL风险恶性率为98.9%(87/88),内镜超声与经皮方法无差异,需进一步验证。

要点

  • 提出7级肾上腺细胞学诊断分类:ND、NN、BACE、NONC、AUS、SM、MAL
  • MAL分类风险恶性率98.9%(87/88),SM随访均恶性,AUS中47.6%恶性
  • 内镜超声引导与经皮穿刺方法间无差异

核心结论

  • 作者提出7级肾上腺细胞学诊断方案,MAL分类风险恶性率为98.9%(87/88)。
  • 唯一不符病例切除报告为「伴显著异型性的肾上腺皮质腺瘤」。
  • 内镜超声引导与经皮方法之间无差异。
  • 需进一步研究验证并使该方法通用化。

研究设计与样本

  • 回顾性电子病历检索7家三级中心肾上腺细胞学标本。
  • 细胞学诊断分为7类: nondiagnostic、nonneoplastic、BACE、NONC、AUS、SM、MAL。
  • 记录同期和/或随访活检和/或切除的组织病理结果(如有)。
  • 共纳入473例肾上腺细胞学病例。

主要发现

  • BACE病例占21.8%,MAL病例占所有病例的57.5%。
  • BACE和MAL分类在有组织病理随访的病例中符合率分别为100%和98.9%。
  • 10例NONC中6例有组织病理诊断,包括3例嗜铬细胞瘤和3例神经鞘瘤。
  • 21例AUS有组织学随访,其中10例(47.6%)为恶性。
  • 6例SM有组织病理随访,随访均为恶性。

关键数值与推荐

  • MAL分类风险恶性率为98.9%(87/88)。
  • BACE与组织病理符合率100%。
  • AUS中恶性比例47.6%(10/21)。
  • SM随访恶性比例100%(6/6)。

临床怎么用

  • 可采用7级分类系统报告肾上腺细胞学标本。
  • MAL和SM分类具有高恶性预测价值。
  • AUS分类需密切随访,因近半数为恶性。

局限性

  • 需进一步研究验证并使该方法通用化。
  • 部分分类(如NONC、AUS、SM)组织病理随访例数有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the development of new technologies and the changing patient profiles, cytopathology departments receive increasing numbers of adrenal gland cytology specimens. In this study, the authors analyzed archival adrenal gland cytology cases and attempted to implement a diagnostic reporting system. DESIGN: Retrospective electronic medical record search was performed for adrenal gland cytology specimens in seven tertiary care centers. The cytology diagnoses were grouped in 7 categories: nondiagnostic, nonneoplastic, benign adrenal cortical elements (BACE), primary neoplasm of noncortical origin (NONC), atypia of undetermined significance (AUS), suspicious for malignancy (SM), and malignant (MAL). If available, histopathology results of concurrent and/or follow-up biopsies and/or resections were documented. RESULTS: A total of 473 adrenal gland cytology cases were included. BACE cases comprised 21.8%, whereas MAL cases were 57.5% of all cases. For BACE and MAL categories, there were 100% and 98.9% correlation, respectively, in the cases with histopathology follow-up. Six of 10 NONC cases had histopathology diagnoses and there were 3 pheochromocytomas and 3 schwannomas. Twenty-one AUS cases had histology follow-up and 10 (47.6%) of them were malignant. Six cases of SM had histopathology follow-up, and all of them were malignant on the follow-up. CONCLUSIONS: The authors propose a 7-tier diagnostic scheme for adrenal gland cytology. The risk of malignancy was 98.9% in MAL cases (87/88) in the cohort. The only case with discordance was reported as "adrenal cortical adenoma with marked atypia"' on resection. There was no difference between endoscopic ultrasound-guided and percutaneous methods. Further studies are needed to validate and make this approach universal.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Trabzonlu L, Jager L, Tabibi S, et al. Adrenal gland cytology reporting: a multi-institutional proposal for a standardized reporting system. Cancer Cytopathol. 2022. PMID: 35244974. doi:10.1002/cncy.22564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。